MacroGenics (MGNX) reported 19.35millioninrevenueforthequarterendedDecember2024,representingayear−over−yearincreaseof80.50.25 for the same period compares to -0.75ayearago.ThereportedrevenuecomparestotheZacksConsensusEstimateof45.26 million, representing a surprise of -57.24%. The company delivered an EPS surprise of -8.70%, with the consensus EPS estimate being -$0.23.While investors scrutinize revenue and earnings changes year-over-year and how they compare with ...